1. Home
  2. LXU vs REPL Comparison

LXU vs REPL Comparison

Compare LXU & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

N/A

Current Price

$8.72

Market Cap

626.6M

Sector

Industrials

ML Signal

N/A

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$9.52

Market Cap

721.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LXU
REPL
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
626.6M
721.7M
IPO Year
1969
2018

Fundamental Metrics

Financial Performance
Metric
LXU
REPL
Price
$8.72
$9.52
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$10.17
$12.00
AVG Volume (30 Days)
460.6K
1.7M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$585,065,000.00
N/A
Revenue This Year
$18.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.49
N/A
52 Week Low
$4.88
$2.68
52 Week High
$9.98
$14.80

Technical Indicators

Market Signals
Indicator
LXU
REPL
Relative Strength Index (RSI) 45.71 49.87
Support Level $8.65 $9.63
Resistance Level $9.92 $10.29
Average True Range (ATR) 0.29 0.58
MACD -0.04 -0.16
Stochastic Oscillator 7.65 8.64

Price Performance

Historical Comparison
LXU
REPL

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: